Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors - Concepedia

Concepedia

Publication | Closed Access

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

70

Citations

21

References

2008

Year

Patricia LoRusso, Shirish M. Gadgeel, Antoinette Wozniak, Alan Barge, Helen Jones, Zachary DelProposto, Pamela DeLuca, Jeffrey L. Evelhoch, Scott A. Boerner, Catherine Wheeler

Investigational New Drugs

Drug TargetingAngiogenesisSolid TumorsMedicinePharmacologyVascular BiologyPharmacotherapyTumor TargetingNeovascularizationClinical EvaluationOncologyRadiation OncologyNovel Vascular-targeting Agent

References

	Year	Citations

Page 1

Page 1